-
Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
-
Health Advisory: Nirsevimab supplies limited
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…
-
Kitsap Respiratory Illness Report: Nov. 12 to Nov. 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 46 of the Kitsap Respiratory Illness Report. In the week ending on Nov. 18, Kitsap Public Health District saw increasing numbers of labs positive for respiratory syncytial virus (RSV) and influenza reported by our sentinel respiratory reporting laboratories, indicating that RSV and flu are rising locally. Local COVID-19 indicators remain low.…
-
Health Advisory: Nirsevimab supplies limited
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details. ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure…
-
Providers advised to vaccinate all children against HPV beginning at age nine
Advisory or Update, HIV & STDs, Immunization, Immunizations, News and Update, Prevention, Provider Resources, SchoolsHPV vaccines are safe and highly effective in preventing infection with cancer-causing strains of HPV. The American Cancer Society, the American Academy of Pediatrics, and the CDC Advisory Committee on Immunization Practices (ACIP), and now the Washington Department of Health recommend starting this vaccination series at age 9. The HPV vaccine is one of the…
-
Kitsap Public Health joins other local public health agencies in supporting continued masking in healthcare settings
Regional healthcare facilities across the Puget Sound region have issued a statement to continue requiring masking in acute care and outpatient clinic settings. A regional consensus ensures a consistent and clear message that these healthcare facilities prioritize the health and safety of both their patients and employees. Local public health agencies in our region, including…
-
Kitsap Respiratory Illness Report: March 12 – March 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 11 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 6 positive influenza tests in the past week (1,705 cumulative (16.1% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (491 since the start of…
-
Kitsap Respiratory Illness Report: March 5 – March 11
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 10 of the Kitsap Respiratory Illness Report: 03.05.23-03.11.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,693 cumulative (17.0% of total tested) since10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (490 since the start of the…
-
Health Advisory: Increase in Extensively Drug-Resistant Shigellosis
Advisory or Update, Health Advisory, Health Alert, Infection Control, Notifiable Conditions, Provider ResourcesActions requested Background Centers for Disease Control and Prevention (CDC) is monitoring an increase in XDR Shigella infections (shigellosis) reported through national surveillance systems. In 2022, about 5% of Shigella infections reported to CDC were XDR strains, compared with 0% in 2015. CDC defines XDR Shigella bacteria as strains resistant to all commonly recommended antibiotics: azithromycin,…
-
Kitsap Respiratory Illness Report: February 26 – March 4
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Novel Coronavirus, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 9 of the Kitsap Respiratory Illness Report: 02.26.23-03.04.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,693 cumulative (17.0% of total tested) since 10/2/2022). RSV activity is currently low, with 0 positive RSV tests in the past week (490 since the start of the…
-
Health Advisory: Updates on Buprenorphine and Controlled Substances Prescribing, Overdose Data, Naloxone, and Xylazine
Actions requested Contacting the health district
-
Kitsap Respiratory Illness Report: February 19 – February 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.19.23-02.25.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,691 cumulative (17.6% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (490 since the start of…
-
Health Advisory: Increase COVID-19 Treatment Access, Prescribing and Uptake
Advisory or Update, COVID-19, Health Advisory, Health Alert, Immunization, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Provider ResourcesActions requested For questions, please contact our Immunizations/COVID Program at 360-728-2007. Background While COVID-19 treatment is shown to reduce hospitalization, it is under-used for high-risk patients with acute COVID-19. High-risk patients include: COVID-19 continues to cause between 2,000 and 4,000 deaths each week in the United States (see CDC’s Trends in Number of COVID-19 Cases…
-
Kitsap Respiratory Illness Report: February 12 – February 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.12.23-02.18.23. Summary: Local influenza activity is currently low, with 9 positive influenza tests in the past week (1,689 cumulative (18.2% of total tested) since 10/2/2022). RSV activity is currently low, with 4 positive RSV tests in the past week (488 since the start of…
-
Kitsap Respiratory Illness Report: February 5 – February 11
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 6 of the Kitsap Respiratory Illness Report: 02.05.23-02.11.23. Summary: Local influenza activity is currently low, with 5 positive influenza tests in the past week (1,680 cumulative (18.9% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (484 since the start of…
-
Kitsap Respiratory Illness Report: January 29 – February 4
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness ReportClick here to access week 4 of the Kitsap Respiratory Illness Report: 01.29.23-02.04.23. Summary: Local influenza activity is currently low, with 4 positive influenza tests in the past week (1,675 cumulative (19.7% of total tested) since 10/2/2022). RSV activity is currently elevated, with 6 positive RSV tests in the past week (482 since the start of…